General Provisions Relating to Drugs and Devices

  1. Law
  2. USC 21
  3. Food And Drugs
  4. FEDERAL FOOD, DRUG, AND COSMETIC ACT
  5. DRUGS AND DEVICES
  6. General Provisions Relating to Drugs and Devices

Checkout our iOS App for a better way to browser and research.

Section
360bbb

Expanded access to unapproved therapies and diagnostics

Section
360bbb–0

Expanded access policy required for investigational drugs

Section
360bbb–0a

Investigational drugs for use by eligible patients

Section
360bbb–1

Dispute resolution

Section
360bbb–2

Classification of products

Section
360bbb–3

Authorization for medical products for use in emergencies

Section
360bbb–3a

Emergency use of medical products

Section
360bbb–3b

Products held for emergency use

Section
360bbb–3c

Expedited development and review of medical products for emergency uses

Section
360bbb–4

Countermeasure development, review, and technical assistance

Section
360bbb–4a

Priority review to encourage treatments for agents that present national security threats

Section
360bbb–4b

Medical countermeasure master files

Section
360bbb–5

Critical Path Public-Private Partnerships

Section
360bbb–6

Risk communication

Section
360bbb–7

Notification

Section
360bbb–8

Consultation with external experts on rare diseases, targeted therapies, and genetic targeting of treatments

Section
360bbb–8a

Optimizing global clinical trials

Section
360bbb–8b

Use of clinical investigation data from outside the United States

Section
360bbb–8c

Patient participation in medical product discussion

Section
360bbb–8d

Notification, nondistribution, and recall of controlled substances